Key facts
- Manuals
- 1
- Languages
- EN
- Last added
- 2023-11-15
Featured MSAC manuals

MSAC Ratified PICO Confirmation Application 1555 Endoscopic Sleeve Gastroplasty for Obesity Class I and II
This Ratified PICO Confirmation from February 2019 outlines the Medical Services Advisory Committee (MSAC) assessment framework for Application 1555, which proposes endoscopic sleeve gastroplasty for patients aged 18 years or over with BMI 30.0–39.9 kg/m² who have major medical comorbidities and have failed first- and second-line treatments. The document defines the patient population, intervention (endoscopic sleeve gastroplasty plus lifestyle interventions), comparators (lifestyle interventions alone for BMI 30.0–34.9; sleeve gastrectomy or laparoscopic adjustable gastric banding plus lifestyle for BMI 35.0–39.9), and outcomes including safety, efficacy, healthcare resources, and cost-effectiveness.
The document provides background on obesity prevalence in Australia, noting 4.9 million Australians classified as obese (4.3 million in class I or II), common comorbidities (arthritis 27.7%, hypertension 24.5%, mental health problems 22.6%, diabetes 12.8%), and current chronic disease model of care. Treatment failure is defined as inability to achieve minimum 5% weight loss within 3 months. The rationale considers clinical need for durable weight loss beyond short-term lifestyle interventions.
Covers: Component Description · Population · Obesity Definition and Measurement · Consequences of Obesity · Prevalence of Obesity in Australia · Current Care and Management
Latest MSAC manuals
MSAC Ratified PICO Confirmation Application 1555 Endoscopic Sleeve Gastroplasty for Obesity Class I and II
Other 29 pages · 1.7 MB · ENAustralian MSAC policy assessment document evaluating endoscopic sleeve gastroplasty versus lifestyle interventions and bariatric surgery for class I and II…
Questions answered in MSAC manuals
What is the patient population for endoscopic sleeve gastroplasty in this assessment?
Patients aged 18 years or over with BMI 30.0–39.9 kg/m² who have one or more major medical comorbidities and have failed first- and second-line treatment options.
How is treatment failure defined in this application?
Treatment failure is defined as an inability to achieve a minimum of 5 per cent weight loss within 3 months.
